Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/12679
Pneumococcal Choline-Binding Proteins Involved in Virulence as Vaccine Candidates
Sempere, Julio ISCIII | Llamosi, Mirella ISCIII | Del Rio Menendez, Idoia ISCIII | Lopez Ruiz, Beatriz ISCIII | Domenech Lucas, Mirian ISCIII | Gonzalez-Camacho, Fernando ISCIII
Vaccines (Basel). 2021 Feb 20;9(2):181.
Streptococcus pneumoniae is a pathogen responsible for millions of deaths worldwide. Currently, the available vaccines for the prevention of S. pneumoniae infections are the 23-valent pneumococcal polysaccharide-based vaccine (PPV-23) and the pneumococcal conjugate vaccines (PCV10 and PCV13). These vaccines only cover some pneumococcal serotypes (up to 100 different serotypes have been identified) and are unable to protect against non-vaccine serotypes and non-encapsulated pneumococci. The emergence of antibiotic-resistant non-vaccine serotypes after these vaccines is an increasing threat. Therefore, there is an urgent need to develop new pneumococcal vaccines which could cover a wide range of serotypes. One of the vaccines most characterized as a prophylactic alternative to current PPV-23 or PCVs is a vaccine based on pneumococcal protein antigens. The choline-binding proteins (CBP) are found in all pneumococcal strains, giving them the characteristic to be potential vaccine candidates as they may protect against different serotypes. In this review, we have focused the attention on different CBPs as vaccine candidates because they are involved in the pathogenesis process, confirming their immunogenicity and protection against pneumococcal infection. The review summarizes the major contribution of these proteins to virulence and reinforces the fact that antibodies elicited against many of them may block or interfere with their role in the infection process.
Files in this item
- PneumococcalCholineBindingProt ...